Pharmaceutical companies are facing uncertainty and cost pressure at an unprecedented level today. The mandate for RE & FM organizations is to increase scalability, efficiency, and asset utilization. UMS has been retained by leading biotechnology and pharmaceutical companies on a number of landmark FM improvement efforts on a global scale. Our tools and expertise has helped bio-pharmaceutical companies improve internal business partnerships, efficiency, process effectiveness and agility in complex cGXP environments. In particular, UMS has helped clients in this sector understand competitive benchmark performance, develop process effectiveness, define core competencies, and develop outsourcing strategies for non-core activities in the context of cultural readiness. UMS brings an in-depth understanding of the inter-relationship between FM services and the core scientific discovery, development, and manufacturing processes.